Detalles de la búsqueda
1.
Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients.
Clin Exp Hypertens
; 40(7): 637-643, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29265934
2.
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.
J Card Fail
; 22(10): 815-22, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26721775
3.
Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study.
J Card Fail
; 21(3): 179-88, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25573829
4.
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
Eur Heart J
; 35(7): 431-41, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24255129
5.
Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF).
J Card Fail
; 20(1): 45-52, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24269854
6.
Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.
Curr Heart Fail Rep
; 11(1): 19-30, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24363020
7.
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?
Eur J Heart Fail
; 20(2): 317-322, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28871621
8.
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.
Circ Heart Fail
; 11(5): e004644, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748350
9.
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
Eur J Heart Fail
; 19(6): 739-747, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296139
10.
The benefits and safety of external counterpulsation in symptomatic heart failure.
Isr Med Assoc J
; 8(10): 687-90, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17125114
11.
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Eur J Heart Fail
; 18(8): 1041-50, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114058
12.
Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
Eur J Heart Fail
; 18(10): 1248-1258, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27206810
13.
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study.
J Am Coll Cardiol
; 41(2): 204-10, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12535809
14.
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome.
Eur J Heart Fail
; 7(5): 815-9, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16087136
15.
Management of cardiac arrest in 2005: an update.
Isr Med Assoc J
; 7(9): 589-94, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16190484
16.
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
Eur J Heart Fail
; 17(11): 1133-43, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26333529
17.
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.
Eur J Heart Fail
; 17(7): 697-706, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26083764
18.
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
Am Heart J
; 147(2): 293-300, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14760328
19.
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Am Heart J
; 145(4): 622-7, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12679757
20.
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction.
Psychosom Med
; 66(4): 521-6, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15272097